Bat Genome Study Reveals ISG15 Gene Can Reduce SARS-COV-2 Production by 90%

Breakthrough Discovery: Bat Genome Holds Key to Viral Resistance

Five years after the onset of the COVID-19 pandemic, scientists continue to uncover the long-term effects of the virus and seek ways to mitigate them in the future. A significant leap forward in this ongoing research has come from a study involving an international team of researchers, with the participation of the Ray Laboratory at Texas Tech University.

Understanding Bat Immunity

Bat1K, a global project aiming to sequence all 1,500 living bat species, gave the international team the opportunity to study the genomes of these creatures, which have shown remarkable abilities to resist viral infections.

At the forefront of this endeavor is the Ray Laboratory, led by Professor David Ray from the Department of Biological Sciences at Texas Tech University. The lab has specialized in the study of transposable elements (TEs) and their role in genome evolution, making them invaluable contributors to the research.

The Role of Transposable Elements

Transposable elements are bits of DNA that can create copies of themselves within a genome, introducing genetic diversity within a species. This characteristic makes TEs particularly important for understanding how bats maintain their resilience against viruses.

“Bats have a unique TE repertoire among mammals, presenting a powerful way to generate new genetic pathways to deal with pathogens like the coronavirus,” explains Ray.

Discovering the ISG15 Gene

Researchers focused on a gene called ISG15, which while associated with severe cases of COVID-19 in humans, seems to play a protective role in bats.

“The ISG15 gene from bats is able to reduce the production of the SARS-CoV-2 virus by 80-90%. By contrast, the human version of the gene has shown no antiviral effect in this study,” shares Michael Hiller, a professor of comparative genomics at the Goethe University, and a member of the Senckenberg Institute.

Implications for Medical Research

The discovery of the ISG15 gene in bats offers a foundation for future medical advancements in virus resistance. Understanding how this gene functions so effectively in bats could lead to new treatments and preventive measures for humans.

“This study represents a crucial step in deciphering the unique adaptations of the bats’ immune system,” says Hiller.

Ray also underscores the importance of genetic diversity in species survival. He notes that genetic variation, facilitated by TEs, allows some individuals to better withstand environmental pressures, such as viral diseases.

The Role of Bat1K

The study is part of the Bat1K project, a comprehensive initiative to sequence and assemble the genomes of every known bat species. The Senckenberg Research Institute in Germany oversee the project, ensuring collaboration among leading scientists worldwide.

This collaborative effort highlights the significance of interdisciplinary and international research in advancing medical science.

Conclusion

The discovery made by the Ray Laboratory, in conjunction with an international team of researchers, brings hope for new medical solutions in combating viral diseases. By understanding the mechanisms that make bats resistant to pathogens, scientists can potentially develop more effective treatments and preventive measures for human diseases.

As research continues, this groundbreaking study demonstrates the potential of collaboration and the power of exploring the natural world for answers to human health problems.

What do you think about this discovery? Share your thoughts in the comments below, or subscribe to our newsletter for more updates on groundbreaking scientific research!

The post Bat Genome Study Reveals ISG15 Gene Can Reduce SARS-COV-2 Production by 90% appeared first on Archynetys.

Source link

Leave a Comment